Treatment of Functional Abdominal Distension
NCT04043208 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32
Last updated 2022-02-22
Summary
Background. Abdominal distention is produced by an abnormal somatic postural tone. We developed an original biofeedback technique based on electromyography-guided control of abdominothoracic muscular activity. In a randomized, placebo-controlled trial we demonstrated the superiority of biofeedback over placebo for the treatment of abdominal distention. However, the technique is technically complex and unpractical.
Aim. To prove the efficacy of a simplified biofeedback technique for the treatment of abdominal distension.
Selection criteria. Visible abdominal distension after meal ingestion; patients are able to identify the offending meal.
Intervention. Patients will be randomized into biofeedback in placebo groups.Three sessions of either biofeedback or placebo intervention will be performed 30 min after ingestion of the offending meal during the first 3 weeks of the intervention period.
Biofeedback: patients will be taught to control abdominal and thoracic muscular activity by providing a visual display of the abdominal and thoracic perimeter; specifically, they will be instructed to reduce the abdominal perimeter (girth); patients will be instructed to perform the same exercises before and after breakfast, lunch and dinner during the 4-week intervention period.
Placebo: abdominal and thoracic perimeter will be recorded but not shown to the patient and a pill of placebo containing 0.5 g glucose will be administered; patients will be instructed to take a pill of placebo before breakfast, lunch and dinner during the 4-week intervention period.
Primary Outcome Measure:
Effect of the probe meal on the activity of thoraco-abdominal muscles (intercostals, external oblique, internal oblique, upper rectus, lower rectus) measured by electromyography before and after the probe meal. The response to the probe meal will be measured before and after treatment.
Secondary Outcome Measures:
* Effect of the probe meal on sensation of abdominal distension measured by 0-6 scales after the probe meal.
* Changes in girth produced by the probe meal measured using a non-stretch belt placed over the umbilicus before and after the probe meal.
* Sensation of abdominal distension measured by 0-6 scales after each meal (breakfast, lunch, dinner) over a 7-day clinical evaluation period before and during the 4th week of the intervention.
Conditions
- Irritable Bowel Syndrome
- Dyspepsia
Interventions
- BEHAVIORAL
-
Biofeedback
Three sessions of biofeedback will be performed during the first 3 weeks of the intervention period. Biofeedback sessions will be performed 30 min after ingestion of the offending meal: patients will be taught to control abdominal and thoracic muscular activity by providing a visual display of the abdominal and thoracic perimeter; specifically, they will be instructed to reduce the abdominal perimeter (girth). Patients will be instructed to perform the same exercises before and after breakfast, lunch and dinner during the 4-week intervention period.
- DIETARY_SUPPLEMENT
-
Placebo
Three sessions will be performed during the first 3 weeks of the intervention period. Each session will be performed 30 min after ingestion of the offending meal: abdominal and thoracic perimeter will be recorded but not shown to the patient; patients will take a pill of placebo containing 0.5 g glucose and no specific instructions will be provided. Patients will be instructed to take a pill of placebo before breakfast, lunch and dinner during the 4-week intervention period.
Sponsors & Collaborators
-
Hospital Universitari Vall d'Hebron Research Institute
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-07-25
- Primary Completion
- 2021-01-19
- Completion
- 2022-01-17
Countries
- Spain
Study Locations
More Related Trials
-
EFFECTIVENESS OF ULTRASOUND FOR LOCAL FAT TREATMENT
NCT04043182 ·Status: UNKNOWN ·Phase: NA
-
Esophageal Balloon Measurements to Better Characterize Thoraco-abdominal Interrelationship Mechanics.
NCT03624491 ·Status: COMPLETED ·Phase: NA
-
Whole Body Vibration After Bariatric Surgery
NCT05695599 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
An Open-Label Study to Evaluate Retreatment With LIPO-202
NCT02397525 ·Status: UNKNOWN ·Phase: PHASE2
-
Ultrasound-induced Adipose Tissue Cavitation and Training in Obesity
NCT04417816 ·Status: TERMINATED ·Phase: NA
-
Residual Gastric Volume Measured by Ultrasound in Diabetic Surgical Population Versus Non-diabetic Surgical Population.
NCT05435157 ·Status: COMPLETED
-
Comparative Study of Intragastric Balloon and Pharmacotherapy for Non-Morbid Obesity
NCT00355979 ·Status: UNKNOWN ·Phase: PHASE3
-
Fecal Microbial Transplantation and Fiber Supplementation in Participants With Obesity and Metabolic Syndrome.
NCT03477916 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of a Probiotic on Visceral Fat Accumulation
NCT02921217 ·Status: UNKNOWN ·Phase: PHASE3
-
Medical Supervised Duodenal-Enteral Feeding Treatment
NCT03542864 ·Status: COMPLETED ·Phase: NA
-
Endoscopic Bariatric Therapies (EBTs): A Retrospective and Prospective Multicenter Registry
NCT04494048 ·Status: RECRUITING
-
Percutaneous Electroneurostimulation of Dermatome T6 for Appetite Reduction and Weight Loss in Morbidly Obese Patients
NCT01792947 ·Status: COMPLETED ·Phase: NA
-
A Study of BioEnterics® Intragastric Balloon (BIB®) System to Assist in the Weight Management of Obese Subjects
NCT00730327 ·Status: COMPLETED ·Phase: NA
-
Gastric Electrical Stimulation (GES) for the Treatment of Obesity
NCT01823705 ·Status: COMPLETED ·Phase: NA
-
Investigation of the Evolution of Gastric Emptying by Gastric Ultra Sonography in Patients Treated With GLP-1 Receptor Agonists on a 7 Days Pausing Period.
NCT06388213 ·Status: NOT_YET_RECRUITING
-
The Effects of Body Contouring: Abdominoplasty and Liposuction
NCT02151799 ·Status: COMPLETED ·Phase: PHASE4
-
Endoscopical Dilation of Benign Esophageal Strictures
NCT01738997 ·Status: COMPLETED ·Phase: NA
-
Chewing, Swallowing and Orofacial Motricity in Severe Obese
NCT05516693 ·Status: UNKNOWN ·Phase: NA
-
Pain Assessment Following Placement of a Percutaneous Radiologic Gastrostomy and Predictive Factors
NCT05618392 ·Status: RECRUITING
-
A Scintigraphic Study to Investigate the Effect of Gelesis100 on Gastric Emptying in Overweight and Obese Subjects
NCT02487602 ·Status: COMPLETED ·Phase: NA
-
Use of an Endoluminal-suturing Device for Endoscopic Gastric Reduction as an Aid for Class I Obesity, or Class II Obesity Without Comorbidity
NCT03900481 ·Status: TERMINATED ·Phase: NA
-
Bedside Observation by Clinical Ultrasound for Stomach Expansion
NCT07312890 ·Status: RECRUITING ·Phase: NA
-
Single-center, Feasibility Study to Evaluate the Use and Safety of the Percutaneous Ultrasound Gastrostomy Technique
NCT03956277 ·Status: UNKNOWN
-
Abdomen - Fat Reduction and Muscle Toning
NCT04587804 ·Status: COMPLETED ·Phase: NA
-
Bariatric Electrical Impedance Tomography
NCT05187039 ·Status: COMPLETED